Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes

Soyeon Lim, Byeong Wook Song, Min Ji Cha, Eun Ju Choi, On Ju Ham, Chang Yeon Lee, Seong Yong Choi, Se Yeon Lee, Yangsoo Jang, Ki Chul Hwang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Regucalcin (SMP30) has been proposed to be involved in the maintenance of calcium homeostasis. Although the expression of regucalcin was regulated in the liver and kidney during the embryogenesis and maturation of these tissues, the roles of regucalcin were not defined yet in heart. This study focused on the investigation of the differential expression changes in regucalcin and its function in hypoxic cardiomyocytes. The expression level of regucalcin was the highest in 7 days after neonatal stage of rat heart. In hypoxic condition, reactive oxygen species (ROS) production and calcium level were decreased in regucalcin-over expressed cardiomyocytes about 60% compared to normal cells. Regucalcin-transfected cells were slowly induced cell death in H 2O2 treated condition and not reduced proliferation in hypoxic condition. In proliferation-related signals, PKC-MEK1/2-ERK1/2 activation of regucalcin-over expressed cells was recovered in hypoxia, compared to hypoxic cardiomyocytes, and expression of proto-oncogene was only affected c-myc by regucalcin. Transfected cardiomyocytes demonstrated that apoptotic signal was hampered in regucalcin-regulated manner. In conclusion, these data suggest that regucalcin may regulate proliferation and cell death in cardiomyocytes via calcium homeostasis.

Original languageEnglish
Pages (from-to)1273-1281
Number of pages9
JournalTissue Engineering and Regenerative Medicine
Volume6
Issue number13
Publication statusPublished - 2009 Oct 1

Fingerprint

Cardiac Myocytes
Calcium
Cell death
Homeostasis
Cell Death
Liver
Rats
Chemical activation
Proto-Oncogenes
Tissue
Oxygen
Embryonic Development
Reactive Oxygen Species
Maintenance
Kidney

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Lim, S., Song, B. W., Cha, M. J., Choi, E. J., Ham, O. J., Lee, C. Y., ... Hwang, K. C. (2009). Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes. Tissue Engineering and Regenerative Medicine, 6(13), 1273-1281.
Lim, Soyeon ; Song, Byeong Wook ; Cha, Min Ji ; Choi, Eun Ju ; Ham, On Ju ; Lee, Chang Yeon ; Choi, Seong Yong ; Lee, Se Yeon ; Jang, Yangsoo ; Hwang, Ki Chul. / Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes. In: Tissue Engineering and Regenerative Medicine. 2009 ; Vol. 6, No. 13. pp. 1273-1281.
@article{8bec420b99814d6dab964b2ed69e9615,
title = "Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes",
abstract = "Regucalcin (SMP30) has been proposed to be involved in the maintenance of calcium homeostasis. Although the expression of regucalcin was regulated in the liver and kidney during the embryogenesis and maturation of these tissues, the roles of regucalcin were not defined yet in heart. This study focused on the investigation of the differential expression changes in regucalcin and its function in hypoxic cardiomyocytes. The expression level of regucalcin was the highest in 7 days after neonatal stage of rat heart. In hypoxic condition, reactive oxygen species (ROS) production and calcium level were decreased in regucalcin-over expressed cardiomyocytes about 60{\%} compared to normal cells. Regucalcin-transfected cells were slowly induced cell death in H 2O2 treated condition and not reduced proliferation in hypoxic condition. In proliferation-related signals, PKC-MEK1/2-ERK1/2 activation of regucalcin-over expressed cells was recovered in hypoxia, compared to hypoxic cardiomyocytes, and expression of proto-oncogene was only affected c-myc by regucalcin. Transfected cardiomyocytes demonstrated that apoptotic signal was hampered in regucalcin-regulated manner. In conclusion, these data suggest that regucalcin may regulate proliferation and cell death in cardiomyocytes via calcium homeostasis.",
author = "Soyeon Lim and Song, {Byeong Wook} and Cha, {Min Ji} and Choi, {Eun Ju} and Ham, {On Ju} and Lee, {Chang Yeon} and Choi, {Seong Yong} and Lee, {Se Yeon} and Yangsoo Jang and Hwang, {Ki Chul}",
year = "2009",
month = "10",
day = "1",
language = "English",
volume = "6",
pages = "1273--1281",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "13",

}

Lim, S, Song, BW, Cha, MJ, Choi, EJ, Ham, OJ, Lee, CY, Choi, SY, Lee, SY, Jang, Y & Hwang, KC 2009, 'Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes', Tissue Engineering and Regenerative Medicine, vol. 6, no. 13, pp. 1273-1281.

Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes. / Lim, Soyeon; Song, Byeong Wook; Cha, Min Ji; Choi, Eun Ju; Ham, On Ju; Lee, Chang Yeon; Choi, Seong Yong; Lee, Se Yeon; Jang, Yangsoo; Hwang, Ki Chul.

In: Tissue Engineering and Regenerative Medicine, Vol. 6, No. 13, 01.10.2009, p. 1273-1281.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential expression of regucalcin (SMP30) and its function in hypoxic cardiomyocytes

AU - Lim, Soyeon

AU - Song, Byeong Wook

AU - Cha, Min Ji

AU - Choi, Eun Ju

AU - Ham, On Ju

AU - Lee, Chang Yeon

AU - Choi, Seong Yong

AU - Lee, Se Yeon

AU - Jang, Yangsoo

AU - Hwang, Ki Chul

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Regucalcin (SMP30) has been proposed to be involved in the maintenance of calcium homeostasis. Although the expression of regucalcin was regulated in the liver and kidney during the embryogenesis and maturation of these tissues, the roles of regucalcin were not defined yet in heart. This study focused on the investigation of the differential expression changes in regucalcin and its function in hypoxic cardiomyocytes. The expression level of regucalcin was the highest in 7 days after neonatal stage of rat heart. In hypoxic condition, reactive oxygen species (ROS) production and calcium level were decreased in regucalcin-over expressed cardiomyocytes about 60% compared to normal cells. Regucalcin-transfected cells were slowly induced cell death in H 2O2 treated condition and not reduced proliferation in hypoxic condition. In proliferation-related signals, PKC-MEK1/2-ERK1/2 activation of regucalcin-over expressed cells was recovered in hypoxia, compared to hypoxic cardiomyocytes, and expression of proto-oncogene was only affected c-myc by regucalcin. Transfected cardiomyocytes demonstrated that apoptotic signal was hampered in regucalcin-regulated manner. In conclusion, these data suggest that regucalcin may regulate proliferation and cell death in cardiomyocytes via calcium homeostasis.

AB - Regucalcin (SMP30) has been proposed to be involved in the maintenance of calcium homeostasis. Although the expression of regucalcin was regulated in the liver and kidney during the embryogenesis and maturation of these tissues, the roles of regucalcin were not defined yet in heart. This study focused on the investigation of the differential expression changes in regucalcin and its function in hypoxic cardiomyocytes. The expression level of regucalcin was the highest in 7 days after neonatal stage of rat heart. In hypoxic condition, reactive oxygen species (ROS) production and calcium level were decreased in regucalcin-over expressed cardiomyocytes about 60% compared to normal cells. Regucalcin-transfected cells were slowly induced cell death in H 2O2 treated condition and not reduced proliferation in hypoxic condition. In proliferation-related signals, PKC-MEK1/2-ERK1/2 activation of regucalcin-over expressed cells was recovered in hypoxia, compared to hypoxic cardiomyocytes, and expression of proto-oncogene was only affected c-myc by regucalcin. Transfected cardiomyocytes demonstrated that apoptotic signal was hampered in regucalcin-regulated manner. In conclusion, these data suggest that regucalcin may regulate proliferation and cell death in cardiomyocytes via calcium homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=84884567706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884567706&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84884567706

VL - 6

SP - 1273

EP - 1281

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 13

ER -